Lupus Research Alliance News
Lupus Research Alliance Grants $6 Million in First Global Team Science Awards

This Largest-Ever Grant Will Fund Two Projects Examining Why Lupus Differs for Each Person NEW YORK, NY. Sept. 21, 2021. Today, the Lupus Research Alliance is pleased to announce the inaugural recipients of its largest grant to date, the Global Team Science Award, which will fund international, multidisciplinary research teams to unravel lupus heterogeneity with […] READ MORE

LRA Recognizes International Day of Charity

September 2, 2021 The United Nations designated September 5 as the annual International Day of Charity to urge people worldwide to help others through volunteer and philanthropic activities.  The Lupus Research Alliance is happy to join groups around the world in acknowledging this important yearly observance.  We are very proud to be recognized by several independent charity watchdog organizations that monitor and encourage […] READ MORE

Thanks to LADA for Major Donation to Research Funding

August 24, 2021 We give a big thank you to the Lupus and Allied Diseases Association, Inc. (LADA) for their generous donation of $120,000 to support research funded by the Lupus Research Alliance.  The funding is specifically directed to Dr. Zahi Touma at University of Toronto for his Modeling Cognitive Impairment project and Dr. Joyce Chang at Boston Children’s […] READ MORE

A “Call to Arms” for the Lupus Community

August 18, 2021 Many lupus patients are at risk for COVID-19 infection because of treatment with corticosteroids and other immunosuppressive medications and will be eligible for booster vaccination. However, there are large gaps in our understanding of who will benefit from the booster vaccines, what strategies will improve response to the vaccine and the best […] READ MORE

Two Studies Show COVID-19 Vaccines are Well-Tolerated Among Lupus Patients

August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given that the Moderna and Pfizer vaccines are the first mRNA vaccines currently authorized for the emergency use in people, lupus researchers have since worked to answer questions specifically about potential side effects and whether these […] READ MORE

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] READ MORE

COVID-19 Took Significant Toll on People with Lupus

July 29, 2021 A new study showed that people with lupus experienced significant physical and emotional effects in the early months of the COVID-19 pandemic.   Including LRA Scientific Advisory Board member Jane Salmon, MD, researchers at Hospital for Special Surgery and Tufts University in Boston invited 97 patients to complete a questionnaire in the […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates